首页> 外国专利> A method of predicting complications of pre-eclampsia in pregnant women with influenza A H1N1

A method of predicting complications of pre-eclampsia in pregnant women with influenza A H1N1

机译:预测甲型H1N1流感孕妇子痫前期并发症的方法

摘要

Method preeclampsia complications prediction in pregnant women with influenza A H1N1, characterized in that the determined concentrations of vaso-vascular endothelial growth factor (VEGF), receptor protein C (PROCR) and endothelin-1 (ET-1) in the blood serum of pregnant women, is calculated value classification function - R (target severity gestosis points) by the formula: R = 0,155 (PROCR) +3,3 ET-1-0,14 (VEGF), wherein R - target severity gestosis - to 7 points - light 8-11 - the average, 12 or more - heavy; VEGF - concentration of vascular endothelial growth factor coc rows in the serum of pregnant women, pg / ml; PROCR - the concentration of protein C receptor in serum of pregnant ng / ml ET-1 - concentration of endothelin-1 in the serum of pregnant women fmol / ml.
机译:甲型H1N1流感孕妇子痫前期并发症的预测方法,其特征在于,孕妇血清中确定的血管-血管内皮生长因子(VEGF),受体蛋白C(PROCR)和内皮素-1(ET-1)的浓度女性,则通过以下公式计算值分类函数-R(目标严重性妊娠点):R = 0,155(PROCR)+3,3 ET-1-0,14(VEGF),其中R-目标严重性妊娠症-至7点-轻8-11-平均12或更多-重; VEGF-孕妇血清中血管内皮生长因子coc行的浓度,pg / ml; PROCR-孕妇血清中C蛋白受体的浓度ng / ml ET-1-孕妇血清中内皮素1的浓度fmol / ml。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号